Bear Stearns to use Derivatech for FX options

Bear Stearns has taken Derivatech’s FX risk management platform to support its expanding FX options trading and distribution operations in New York and London.

The FX risk management platform will be used to price, book and manage trades throughout their lifecycle, while managing portfolio risk management. It will also act as an aid to creating new hedging structures for clients, said the bank.

The system is currently being deployed and is expected to go live very shortly, said Derivatech.

The bank chose the system as part of an aggressive strategy to grow its exotic FX options and structured products business, said David Schoenthal, global head of FX at Bear Stearns in London. “We’ve seen a larger demand for exotics from European institutional and corporate customers,” he said.

A key reason for choosing DerivaTech’s system was its ability to integrate with the bank’s existing proprietary systems, including its credit and back office software, as well as its STP capabilities and its flexibility to grow with the business, Schoenthal added.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here